SCHEMBL8348345

SCHEMBL8348345

O=C(NCc1ccncc1)c1cc(C(=O)NCc2ccc(F)c(Br)c2)ncn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 6/20 0.62
▸ MMP10 P09238 1/20 0.50
▸ MMP9 P14780 1/20 0.50
▸ MMP8 P22894 1/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ NAMPT P43490 1/20 0.45
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ ANO1 Q5XXA6 1/20 0.42
▸ MAPK14 Q16539 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ MAPK7 Q13164 1/20 0.42
▸ CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8349445 0.86 MMP13 (0.74) MMP13MMP10MMP9MMP8SMN1; SMN2
SCHEMBL8357434 0.86 MMP13 (0.86) MMP13MMP10MMP9MMP8L3MBTL1
SCHEMBL8349489 0.86 MMP13 (0.62) MMP13MMP10MMP9MMP8SMN1; SMN2
SCHEMBL5615854 0.86 MMP13 (0.86) MMP13MMP10MMP9MMP8SMN1; SMN2
SCHEMBL8348635 0.83 MMP13 (0.57) MMP13MMP10MMP9MMP8ALDH1A1
SCHEMBL8349486 0.83 MMP13 (0.57) MMP13MMP10MMP9MMP8SMN1; SMN2
SCHEMBL5616139 0.82 MMP13 (0.78) MMP13MMP10MMP9MMP8SMN1; SMN2
SCHEMBL8358830 0.81 MMP13 (0.77) MMP13MMP10MMP9MMP8
SCHEMBL8347568 0.80 MMP13 (0.61) MMP13MMP10MMP9MMP8SMN1; SMN2
SCHEMBL14602302 0.80 MMP13 (0.75) MMP13MMP10MMP9MMP8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004060883-A1 PYRIMIDINE-4,6-DICARBOXYLIC ACID DIAMIDES FOR USE AS SELECTIVE MMP 13 INHIBITORS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-07-22 — — WO disclosed
Send feedback